Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:59 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 1,165 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sham-device Clear all

Conditions: Overactive Bladder
Interventions: (VERV™ System), Sham version of (VERV™ System); Device
Lead sponsor: Ethicon Endo-Surgery; Industry
Eligibility: 18 Years and older
Enrollment: 163 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 14
States / cities: Tucson, Arizona • Murrieta, California • Washington D.C., District of Columbia + 11 more

Conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS)
Interventions: Zenflow Spring System, Sham Procedure; Device
Lead sponsor: Zenflow, Inc.; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 279 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 7
States / cities: Los Angeles, California • Glenview, Illinois • Las Vegas, Nevada + 3 more

Conditions: Systolic Blood Pressure, Blood Pressure, Depression - Major Depressive Disorder, Anxiety, Sleep Quality, Physical Function, Cognitive Function
Interventions: Inspiratory Muscle Strength Training High-Resistance, Inspiratory Muscle Strength Training Low-Resistance; Device
Lead sponsor: Florida State University; Other
Eligibility: 60 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Hamstring Injury, Muscle Tone Increased, Muscle Pain, Muscle Weakness
Interventions: CLRT; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 35 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Type 2 Diabetes
Interventions: Resonator device, Resonator device - sham; Device
Lead sponsor: pico-tesla Magnetic Therapies, LLC; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Littleton, Colorado

Conditions: Chronic Kidney Disease (CKD) Stages G3 to G5
Interventions: Auricular Vagal Neuromodulation Therapy (AVNT™), Sham-device; Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes, Weight Loss
Interventions: tVNS, Complete Vagotomy, Anterior Vagotomy; Behavioral · Procedure
Lead sponsor: University of Florida; Other
Eligibility: 20 Years to 75 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Post-operative Pain
Interventions: Pulsed Radiofrequency Energy (PRFE), No Pulsed Radiofrequency Energy (PRFE); Device
Lead sponsor: Regenesis Biomedical, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 139 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 3
States / cities: Pasadena, California • Pasadena, Maryland • San Antonio, Texas

Conditions: MacTel (Macular Telangiectasia) Type 2
Interventions: Ciliary neurotrophic factor (CNTF), Surgery; Biological · Procedure
Lead sponsor: Neurotech Pharmaceuticals; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 8
States / cities: Los Angeles, California • Miami, Florida • Atlanta, Georgia + 5 more

Conditions: Asthma Control, Pulmonary Function, Quality of Life, Stress, Sleep Quality
Interventions: Energy Recovery Ventilator, Portable Air Cleaner, Energy Recovery Ventilator (Sham), Portable Air Cleaner (Sham); Device
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 5 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Arlington, Texas • Plano, Texas

Conditions: Keratitis, Corneal Ulcer
Interventions: PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial Tears; Combination Product · Other
Lead sponsor: Peschke GmbH; Industry
Eligibility: 18 Years and older
Enrollment: 488 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 12
States / cities: Littleton, Colorado • Fort Myers, Florida • Tampa, Florida + 9 more

Conditions: Body Contouring
Interventions: Erchonia GLS, Placebo laser; Device
Lead sponsor: Erchonia Corporation; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 2
States / cities: Marion, Indiana • Bloomfield Hills, Michigan

Conditions: COPD, Chronic Bronchitis, Emphysema
Interventions: pneumatic vest, placebo pneumatic vest; Device · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 45 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Spinal Cord Injury
Interventions: robotic training, spinal cord electrical stimulation, treadmill; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 65 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Vertigo
Interventions: Otoband, Sham A, Sham B; Device
Lead sponsor: Otolith Labs; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Malocclusion
Interventions: Fixed Orthodontic Appliance Treatment, OrthoPulse™, Non-Functional OrthoPulse™; Other · Device
Lead sponsor: Biolux Research Holdings, Inc.; Industry
Eligibility: 12 Years to 40 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Suwanee, Georgia

Conditions: Osteoarthritis
Interventions: Self-Administered Acupressure; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 65 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Neuropathic Pain
Interventions: NIN, Sham CES, CES; Device
Lead sponsor: Brooke Army Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Fort Sam Houston, Texas

Conditions: Hypotension
Interventions: Impedance Threshold Device, sham ITD; Device
Lead sponsor: Advanced Circulatory Systems; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Cerebral Palsy, Hemiplegic Cerebral Palsy, Spastic Hemiplegic Cerebral Palsy, Spastic Hemiparesis, Spastic Hemiplegia
Interventions: active transcranial direct current stimulation, bimanual training; Device · Behavioral
Lead sponsor: Burke Medical Research Institute; Other
Eligibility: 6 Years to 18 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: White Plains, New York

Conditions: Moderate to Severe Insomnia
Interventions: Transcranial alternating current stimulator; Device
Lead sponsor: Nexalin Technology; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cognitive Impairment, Cognitive Decline
Interventions: Active tDCS, Sham tDCS; Device
Lead sponsor: University of Florida; Other
Eligibility: 60 Years to 95 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Pain Management, Peripheral Neuropathic Pain
Interventions: Cold Pressor Task - Upper Limb, Algometry Pain Tests in the Upper Limb, Algometry Pain Tests in the Lower Limb; Device
Lead sponsor: Evan (Huiliang) Wang; Other
Eligibility: 20 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Migraine
Interventions: 11-point pain scale, Headache diary, Avulux®, Sham Avulux®; Other · Device
Lead sponsor: Avulux, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 3
States / cities: Minneapolis, Minnesota • Columbus, Ohio

Search by objective public record fields.

Safety and Effectiveness of a Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Overactive Bladder

Safety and Effectiveness Study of the Zenflow Spring System

IMST for Dementia Risk Reduction

Cranial Laser Reflex Technique for Hamstring Function

The Application of Extremely Low Level Magnetic Fields as Adjunctive Treatment for Type II Diabetes

Transcutaneous Auricular Vagal Neuromodulation Therapy (AVNT™) in Chronic Kidney Disease Autonomic Dysfunction

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

Pulsed Radiofrequency Energy to Treat Post-Bunionectomy Pain

Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)

Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study

Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers

Study of the Effectiveness of Green Diode Laser Light on Body Shaping

Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation

Improve Dynamic Lateral Balance of Humans With SCI

Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting

Effect of Intra-Oral Photobiomodulation on Orthodontic Treatment Time

Acupressure for Knee Pain in Older Adults

Combining CES Alpha-Stim and InterX for Optimized Rehabilitation Following Extremity Immobilization

Efficacy Study of a Facemask Device to Treat Hypotension

tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy

HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia

A Mechanistic Study to Investigate tDCS and Working Memory in MCI Patients

Wearable Focused Ultrasound Stimulation for Peripheral Nerve Pain Management

Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches